Li Xiaorong
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Community Screening Study of Diabetic Retinopathy in Tianjin in 2024 (NCT06478407) | Li Xiaorong | 2024-03-28 |
| The Preliminary Safety and Efficacy of RRG001 After Vitrectomy in Subjects With Proliferative Diabetic Retinopathy (PDR) (NCT06412224) | Li Xiaorong | 2023-12-20 |
Track Li Xiaorong automatically
Every clearance here is in the API, with alerts when new ones post.